Alzheimer’s Disease
Participate in an Alzheimer’s Research Study
If you or someone you love has been diagnosed with Alzheimer’s disease, consider participating in a clinical research study.
Participants receive a high standard of care, and health insurance is not necessary to participate. Patients who qualify for our clinical trials receive all study-related care and treatment at no cost. In some cases, you may be compensated for your time and travel. You may even gain access to research treatments before they become widely available.
JNJ 63733657 Study: Early Alzheimer’s Disease
This study is designed for patients ages 55 to 75 years of age who met the criteria for Early Alzheimer’s Disease. This Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to assess the efficacy and safety of JNJ63733657 an Anti-tau Monoclonal Antibody, in participants with Early Alzheimer’s Disease. Study medication will be administered intramuscular (IM). Patients will be evaluated initially to confirm the presence of Amyloid by blood samples, if positive then the confirmation of Tau in the brain will be determined by obtaining a Tau PET scan. There is no charge for evaluation and treatment, and there is compensation to assist with time and travel.
MapLight Study
This study is designed for patients ages 55 to 90 years who have been diagnosed with Alzheimer’s disease and are experiencing hallucinations and / or delusions for at least 2 months before screening visit, also known as Alzheimer’s disease Psychosis. It is a randomized, double-blind, placebo-controlled Phase 2 clinical trial evaluating the safety and effectiveness of ML-007C-MA. Study medication is administered orally. Participants are treated for approximately 7 weeks, during which the study assesses improvement in hallucinations and delusions as well as overall safety and tolerability.
Perhaps the best reason to participate in an Alzheimer’s clinical trial is so that you can take an active role in your health care, by educating yourself regarding your condition. You will obtain access to top quality medical care from our Board Certified physicians at a medical research healthcare facility specializing in Alzheimer’s care.
Without volunteers for clinical trials, improved treatments, including a cure for Alzheimer’s disease can never become a reality.
Articles about Alzheimer’s Disease
To read one of our most recent articles about Alzheimer’s Disease just click the title of the article.
Hearing Loss and Cognitive Decline
Untreated Hearing Loss May Accelerate Cognitive Decline and Dementia Evidence suggests that age-related hearing loss, particularly in those over the age of 65, can lead to cognitive decline and dementia if left untreated. Impairments in communication and psychosocial...
The MIND Diet: Effective Against Cognitive Decline?
What is The MIND Diet? The MIND diet is based on the Mediterranean and DASH (Dietary Approach to Systolic Hypertension) diets, with an emphasis on natural plant-based foods and limited consumption of saturated fats and animal-based foods. The MIND diet, which is...
The MIND Diet for Slowing Age-Related Cognitive Decline
In the search for lifestyle strategies that slow cognitive decline associated with aging, medical researchers have been investigating the protective effects that certain dietary regimens could have on the brain. A study published in the journal Alzheimer’s &...
Burning Calories Increases Brain Volume
A study published in the Journal of Alzheimer’s Disease found that elderly adults who burned off more calories each week through physical exercise saw an increase in brain volume and a subsequent lower risk for Alzheimer’s disease. Although many studies have shown...
Preventing Alzheimer’s with Gene Therapy?
A form of gene therapy has yielded positive findings in the search for a potential cure to Alzheimer’s disease, according to research published from the journal Proceedings of the National Academy of Sciences. Researchers in the United Kingdom from Imperial College...
Addressing Your Risk Factors for Alzheimer’s
The risk factors for Alzheimer's disease are non-modifiable, physiological, and behavioral. Non-modifiable risk factors include age, which is the most prominent risk factor for Alzheimer’s disease. At 65 years of age, our chances of getting Alzheimer’s disease is...
Alzheimer’s Changes the Brain Decades Before Symptoms
According to new research, inflammation brain changes related to Alzheimer’s disease may begin as early as 20 years before symptoms develop. This discovery has significant implications for prevention of the disease, since addressing the inflammation earlier in life...
What is Alzheimer’s disease and What Are the Symptoms?
Overview: Alzheimer’s disease is a chronic, degenerative and progressive disease of the brain characterized by a loss of neurons and synapses and is currently ranked as the 7th leading cause of death in the United States. According to the Alzheimer’s Association, an...
Is There a Link Between Hearing Loss and Alzheimer’s?
Over the years, there have been a growing number of studies that have revealed a link between hearing loss and dementia, which may in turn lead to Alzheimer’s if left untreated. In fact, research has shown that mild hearing loss may double the risk of dementia, while...
Hypertension Linked to Vascular Dementia
High blood pressure, or hypertension, is a growing health problem in many parts of the world that serves as a major risk factor for cardiovascular disease and stroke. In addition, new evidence is emerging on a significant association between high blood pressure and...
Our Doctors
To view a brief description of the specialties and background of each of our physicians click on their name.